Co-expression of different angiogenic factors in external auditory canal cholesteatoma

Acta Oto-Laryngologica

Volumn 124, Issue 5, 2004, Pages 563-568

  Naim, Ramin ^a   Riedel, Frank ^a   Gotte, Karl ^a   Bran, Gregor ^a   Sadick, Haneen ^a   Gossler, Ulrich ^a   Hormann, Karl ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; c Met; External auditory canal cholesteatoma; Hepatocyte growth factor; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BIOTIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STREPTAVIDIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CHOLESTEATOMA; CONTROLLED STUDY; EPITHELIUM; EXTERNAL AUDITORY CANAL; FEMALE; FIBROBLAST; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STAINING; STATISTICAL ANALYSIS;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEATOMA; EAR CANAL; EAR DISEASES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-MET; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3042704655     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310015254     Document Type: Article

References (23)

1. Toynbee J. A specimen of molluscum contagiosum developed in the external auditory meatus. Lond Med Gazette 1850; 46: 811.
2. Piepergerdes MC, Kramer BM, Behnke EE. Keratosis obturans and external auditory canal cholesteatoma. Laryngoscope 1980; 90: 383-91.
3. Anthony PF, Anthony WP. Surgical treatment of external auditory canal cholesteatoma. Laryngoscope 1982; 92: 70-5.
4. Makino K, Amatsu M. Epithelial migration on the tympanic membrane and external canal. Arch Otolaryngol 1986; 243: 39-42.
5. Giacobini P, Giampietro C, Fioretto M, et al. Hepatocyte growth factor/scatter factor facilitates migration of GN-11 immortalized LHRH neurons. Endocrinology 2002; 143: 3306-15.
6. Stoker M, Gherardi E, Perryman M, Grey J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-42.
7. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987; 224: 311-6.
8. Bottaro DP, Rubin JS, Falletto DL, Chan A, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
9. Biesiada E, Razandi M, Levin ER. Egr-1 activates basic fibroblast growth factor transcription. J Biol Chem 1996; 271: 18576-81.
10. Senger DR, Connolly DT, Van de Water L. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990; 50: 1774-8.
11. Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000; 21: 793-8.
12. Naim R, Riedel F, Hormann K. Expression of vascular endothelial growth factor in external auditory canal cholesteatoma. Int J Mol Med 2003; 11: 555-8.
13. Riedel F, Götte K, Li M, Hörmann K, Grandis JR. Abrogation of VEGF expression in human head and neck squamous cell carcinoma cell lines decreases angiogenic activity in vitro and in vivo. Int J Oncol 2003; 23(3): 577-83.
14. Holt JJ. External canal cholesteatoma. Laryngoscope 1992; 102: 608-13.
15. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107: 233-5.
16. Birchmeier W, Birchmeier C. Mesenchymal-epithelial transitions. Bioassays 1994; 16: 305-7.
17. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607-13.
18. Detmar M, Yeo KT, Nagy JA, et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995; 105: 44-50.
19. Gille J, Khalik M, Konig V, Kaufmann R. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol 1998; 111: 1160-5.
20. Wojta J, Kaun C, Breuss JM, et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest 1999; 79: 427-38.
21. Dong G, Chen Z, Li ZY, Yeh N, Bancroft CC, Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinomas. Cancer Res 2001; 61: 5911-8.
22. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodelling. Circulation 1998; 98: 149-56.
23. Sengupta S, Gherardi E, Sellers LA, Wood JM, Fan D. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2003; 23: 69-75.